{
    "Trade/Device Name(s)": [
        "QIAstat-Dx Gastrointestinal Panel 2"
    ],
    "Submitter Information": "QIAGEN GmbH",
    "510(k) Number": "K220062",
    "Predicate Device Reference 510(k) Number(s)": [
        "K140407"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PCH"
    ],
    "Summary Letter Date": "April 4, 2023",
    "Summary Letter Received Date": "April 4, 2023",
    "Submission Date": "May 30, 2024",
    "Regulation Number(s)": [
        "21 CFR 866.3990"
    ],
    "Regulation Name(s)": [
        "Gastrointestinal microorganism multiplex nucleic acid-based assay"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology",
        "parisitology",
        "misc"
    ],
    "Analyte(s)": [
        "Adenovirus F40/F41",
        "Astrovirus",
        "Norovirus GI/GII",
        "Rotavirus A",
        "Campylobacter (C. jejuni, C. coli, C. upsaliensis)",
        "Shigella/Enteroinvasive Escherichia coli (EIEC)",
        "Enteropathogenic Escherichia coli (EPEC)",
        "Enterotoxigenic Escherichia coli (ETEC, lt/st)",
        "Shiga-like toxin-producing Escherichia coli (STEC, stx1/stx2, including E. coli O157 serogroup)",
        "Salmonella",
        "Plesiomonas shigelloides",
        "Yersinia enterocolitica",
        "Cryptosporidium",
        "Cyclospora cayetanensis",
        "Entamoeba histolytica",
        "Giardia lamblia (also known as Giardia intestinalis, Giardia duodenalis)"
    ],
    "Specimen Type(s)": [
        "Preserved stool"
    ],
    "Specimen Container(s)": [
        "Para-Pak C&S transport medium",
        "FecalSwab transport medium"
    ],
    "Instrument(s)/Platform(s)": [
        "QIAstat-Dx Analyzer 1.0"
    ],
    "Method(s)/Technology(ies)": [
        "Multiplexed nucleic acid amplification",
        "Real-time PCR",
        "Reverse transcription PCR",
        "Automated sample preparation"
    ],
    "Methodologies": [
        "Multiplex PCR",
        "RT-PCR",
        "Automated molecular detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Cartridge",
        "Analyzer",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for QIAstat-Dx Gastrointestinal Panel 2, a multiplexed PCR assay system for qualitative detection of viral, bacterial, and parasitic nucleic acids in preserved stool specimens.",
    "Indications for Use Summary": "Aids in the qualitative detection and identification of multiple gastrointestinal viruses, bacteria (including diarrheagenic E. coli/Shigella pathotypes), and parasites directly from preserved stool samples in Para-Pak C&S or FecalSwab from individuals with signs and/or symptoms of GI infection, for use with QIAstat-Dx Analyzer 1.0; results used in conjunction with other clinical, laboratory, and epidemiological data.",
    "fda_folder": "Microbiology"
}